Laxacin

Product NDC: 50488-0901
11-digit product format: 504880901
Labeler code: 50488
Product ID: 50488-0901_1b45f6d1-4436-4b3a-813b-7043c0d0fad6
Type: HUMAN OTC DRUG
Nonproprietary name: Docusate sodium and sennosides
Dosage form: TABLET
Route: ORAL
Labeler: Alexso, Inc
Application: M007
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2018-10-15
Substance: DOCUSATE SODIUM; SENNOSIDES A AND B
Active strength: 50; 8.6 mg/1; mg/1
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Laxacin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DOCUSATE SODIUM	50 mg/1
SENNOSIDES A AND B	8.6 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
F05Q2T2JA0	Internal UNII lookup
1B5FPI42EN	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
998740	Internal RxNorm lookup
2106884	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
0df9abaf-3997-4dde-8003-ae3d8d07cf39	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c6f86816-7da6-43ea-8c25-ac9758311cc5	Product name	1	20220118
252e11b6-1a9a-4283-a242-df2c129c496d	Product name	3	20170717
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50488-0901-1	Laxacin	100 in 1 BOTTLE	TABLET	100		8

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50488-0901-1	EA - Each	50488-0901	933d71c3-b01d-44ff-b256-0bee20827ae8	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DOCUSATE SODIUM	ACTIVE INGREDIENT	F05Q2T2JA0	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
SENNOSIDES A AND B	ACTIVE INGREDIENT	1B5FPI42EN	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
DOCUSATE	ACTIVE MOIETY	M7P27195AG	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
SENNOSIDES A AND B	ACTIVE MOIETY	1B5FPI42EN	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
ANHYDROUS DIBASIC CALCIUM PHOSPHATE	INACTIVE INGREDIENT	L11K75P92J	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
DEXTROSE	INACTIVE INGREDIENT	IY9XDZ35W2	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
DOCUSATE SODIUM	ACTIVE INGREDIENT	F05Q2T2JA0	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
SENNOSIDES A AND B	ACTIVE INGREDIENT	1B5FPI42EN	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
DOCUSATE	ACTIVE MOIETY	M7P27195AG	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
SENNOSIDES	ACTIVE MOIETY	3FYP5M0IJX	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
ANHYDROUS DIBASIC CALCIUM PHOSPHATE	INACTIVE INGREDIENT	L11K75P92J	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
DEXTROSE	INACTIVE INGREDIENT	IY9XDZ35W2	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50488-0901	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO, INC]	8	Current NDC, Legacy NDC, 1 package rows	20241208_0df9abaf-3997-4dde-8003-ae3d8d07cf39.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 11 of 43 · 858 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CVS Pharmacy	SALINE LAXATIVE	CVS Pharmacy	edd58c52-18de-4ec4-aec3-44f3e17607a7	2026-02-17	Warnings	Exact identifier application number: M007
Mineral Oil	MINERAL OIL	United Natural Foods, Inc. dba UNFI	cb7bc571-295f-47c2-ae93-18cba194752c	2026-02-17	Warnings, Adverse reactions	Exact identifier application number: M007
Mineral Oil	MINERAL OIL	Strategic Sourcing Services LLC	e4965086-dcc0-4b34-bb30-81facf7139f3	2026-02-17	Warnings, Adverse reactions	Exact identifier application number: M007
Magnesium Citrate	MAGNESIUM CITRATE	Valu Merchandisers Company	cd3e5836-b2f0-41f3-8623-3105c4642491	2026-02-16	Warnings, Adverse reactions	Exact identifier application number: M007
citroma	MAGESIUM CITRATE	Valu Merchandisers Company	a693f6b0-0679-4609-9ca0-dddfa4158c02	2026-02-16	Warnings, Adverse reactions	Exact identifier application number: M007
citroma	MAGNESIUM CITRATE	Valu Merchandisers Company	fb358bc3-e479-42e7-8aea-a6a3676f2430	2026-02-16	Warnings, Adverse reactions	Exact identifier application number: M007
Epsom Salt	MAGNESIUM SULFATE	Valu Merchandisers Company	ff539c1c-9ed3-49be-9b30-1858f12e1e90	2026-02-16	Warnings, Adverse reactions	Exact identifier application number: M007
Castor Oil	CASTOR OIL	United Natural Foods, Inc. dba UNFI	bd19bea3-5ac9-4f8d-b1a0-478fd9c8a01f	2026-02-16	Warnings, Adverse reactions	Exact identifier application number: M007
Walgreens SmoothLAX Soft Chews	MAGNESIUM HYDROXIDE	Walgreens	424e27ce-0b11-9cd2-e063-6294a90a3c21	2026-02-16	Warnings	Exact identifier application number: M007
citroma	MAGNESIUM CITRATE	United Natural Foods, Inc. dba UNFI	da013c15-3531-4dc5-b122-bfc99bc494ae	2026-02-16	Warnings, Adverse reactions	Exact identifier application number: M007
citroma	MAGNESIUM CITRATE	United Natural Foods, Inc. dba UNFI	db1bc651-1a35-4f92-a917-c6a19f421594	2026-02-16	Warnings, Adverse reactions	Exact identifier application number: M007
Stool Softener Laxative	DOCUSATE SODIUM	The Kroger Co.	e1a68bd9-d31a-46a6-8c08-7ad8197b6e0b	2026-02-13	Warnings	Exact identifier application number: M007
Epsom Salt	MAGNESIUM SULFATE	Topco Associates LLC	b2ec06b3-647d-49ab-a392-6db63d96d1e3	2026-02-13	Warnings, Adverse reactions	Exact identifier application number: M007
Castor Oil	CASTOR OIL	Topco Associates LLC	5643f2e0-93e2-4c2e-90a0-fd152150d18a	2026-02-13	Warnings, Adverse reactions	Exact identifier application number: M007
citroma	MAGESIUM CITRATE	Topco Associates LLC	d3cc7cb6-098e-413c-b1ad-7ebf5fa35269	2026-02-13	Warnings, Adverse reactions	Exact identifier application number: M007
citroma	MAGNESIUM CITRATE	Topco Associates LLC	bc89c4bc-5207-479d-9a3b-e570b412a7ba	2026-02-13	Warnings, Adverse reactions	Exact identifier application number: M007
Epsom Salt	MAGNESIUM SULFATE	Topco Associates LLC	72f69aa0-381a-4e5c-975d-3a73fdc1b377	2026-02-13	Warnings, Adverse reactions	Exact identifier application number: M007
Mineral Oil	MINERAL OIL	Topco Associates LLC	e9b1fd61-c229-4529-82c2-d6ac5b076082	2026-02-13	Warnings	Exact identifier application number: M007
Magnesium Citrate	MAGNESIUM CITRATE	Pinnacle RX LLC	4abbb0e4-e005-bc4e-e063-6394a90a126a	2026-02-13	Warnings, Adverse reactions	Exact identifier application number: M007
365 Whole Foods Market Epsom Salt	MAGNESIUM SULFATE	Whole Foods Market, Inc.	4147cdd0-57f6-3857-e063-6394a90afecb	2026-02-12	Warnings, Adverse reactions	Exact identifier application number: M007

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
F05Q2T2JA0	DOCUSATE SODIUM	577-11-7	DOCUSATE SODIUM
1B5FPI42EN	SENNOSIDES A AND B	62211-03-4	SENNOSIDES A AND B

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2106884	Laxacin 50 MG / 8.6 MG Oral Tablet	PSN	0df9abaf-3997-4dde-8003-ae3d8d07cf39	8
998740	sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet	PSN	0df9abaf-3997-4dde-8003-ae3d8d07cf39	8
2106884	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin]	SBD	0df9abaf-3997-4dde-8003-ae3d8d07cf39	8
998740	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SCD	0df9abaf-3997-4dde-8003-ae3d8d07cf39	8
998740	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SY	0df9abaf-3997-4dde-8003-ae3d8d07cf39	8
2106884	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin]	SY	0df9abaf-3997-4dde-8003-ae3d8d07cf39	8
2106884	Laxacin 50 MG / 8.6 MG Oral Tablet	SY	0df9abaf-3997-4dde-8003-ae3d8d07cf39	8
2106884	Laxacin 50 MG / 8.6 MG Oral Tablet	PSN	57fca238-ba1e-4b05-abda-a8333da8132a	2
2106884	Laxacin 50 MG / 8.6 MG Oral Tablet	PSN	fe7d4d75-0f8a-1e7d-e053-6394a90afb4d	2
998740	sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet	PSN	57fca238-ba1e-4b05-abda-a8333da8132a	2
998740	sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet	PSN	fe7d4d75-0f8a-1e7d-e053-6394a90afb4d	2
2106884	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin]	SBD	57fca238-ba1e-4b05-abda-a8333da8132a	2
2106884	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin]	SBD	fe7d4d75-0f8a-1e7d-e053-6394a90afb4d	2
998740	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SCD	57fca238-ba1e-4b05-abda-a8333da8132a	2
998740	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SCD	fe7d4d75-0f8a-1e7d-e053-6394a90afb4d	2
998740	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SY	57fca238-ba1e-4b05-abda-a8333da8132a	2
998740	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SY	fe7d4d75-0f8a-1e7d-e053-6394a90afb4d	2
2106884	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin]	SY	57fca238-ba1e-4b05-abda-a8333da8132a	2
2106884	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin]	SY	fe7d4d75-0f8a-1e7d-e053-6394a90afb4d	2
2106884	Laxacin 50 MG / 8.6 MG Oral Tablet	SY	57fca238-ba1e-4b05-abda-a8333da8132a	2
2106884	Laxacin 50 MG / 8.6 MG Oral Tablet	SY	fe7d4d75-0f8a-1e7d-e053-6394a90afb4d	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50488-0901-1	50488090101	100 TABLET in 1 BOTTLE (50488-0901-1)	100 tablet	2018-10-15	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Laxacin Tablets	Advanced Rx Pharmacy of Tennessee, LLC	2024-12-31	HUMAN OTC DRUG LABEL	2
Laxacin Laxative Plus Stool Softener	Alexso, Inc	2024-12-04	HUMAN OTC DRUG LABEL	8
Laxacin Laxative Plus Stool Softener	Quality Care Products, LLC	2023-12-21	HUMAN OTC DRUG LABEL	2
LAXACIN	Direct_Rx	2023-10-06	HUMAN OTC DRUG LABEL	3
Laxacin Laxative Plus Stool Softener	NuCare Pharmaceuticals,Inc.	2021-02-11	HUMAN OTC DRUG LABEL	5
Laxacin Laxative Plus Stool Softener	medsource pharmaceuticals	2018-12-20	HUMAN OTC DRUG LABEL	2
LAXACIN	DIRECT RX	2018-03-26	HUMAN OTC DRUG LABEL	1
Laxacin Laxative Plus Stool Softener	Dispensing Solutions, Inc. \| PSS World Medical, Inc.	2013-07-12	HUMAN OTC DRUG LABEL	2